Merrimack Pharmaceuticals (MACK) Q4 2022 Earnings

9MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.67
-0.46
-0.24
-0.03

Details

Expected EPS
N/A
Actual EPS
-0.03
Surprise EPS
-0.03
Surprise Percent
+∞%

Description

Merrimack Pharmaceuticals (MACK) has reported earnings of -0.03 per share for Q4 2022.

0 Comments

Share your thoughts